Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 26, 2017 07:00 ET | Source: Pluristem Therapeutics Inc.

Pluristem Receives Positive Feedback from FDA and EMA as Company Prepares for Phase III Trial of PLX-PAD to Support Recovery from Hip Fracture

Trial was recently awarded $8.7 million grant from the European Horizon 2020 programPluristem plans to use results of trial to achieve marketing approval in both the U.S. and Europe HAIFA, Israel,...
September 26, 2017 07:00 ET | Source: Evogene

Evogene & Rahan Meristem announce positive results in 2nd year field trials addressing Black Sigatoka disease in banana and the utilization of the results for genome editing

REHOVOT and ROSH HANIKRA, Israel, Sept. 26, 2017 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ:EVGN) (TASE:EVGN), a leading company for the improvement of crop productivity, and Rahan Meristem (1998)...
September 18, 2017 07:00 ET | Source: Pluristem Therapeutics Inc.

U.S. FDA Grants Fast Track Designation to Pluristem's PLX-PAD for the Treatment of Critical Limb Ischemia (CLI)

Pluristem’s Ongoing Phase III CLI trial has been selected for accelerated approval pathways in both the U.S. and EuropeFast Track Designation allows for expedited review of drugs to treat serious...
September 18, 2017 07:00 ET | Source: Kamada Ltd.

Kamada Announces CFO Transition

Gil Efron, Deputy CEO and CFO, to Depart Kamada at End of Year; Chaime Orlev to Assume CFO Duties REHOVOT, Israel, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ:KMDA) (TASE:KMDA), a...
September 13, 2017 07:00 ET | Source: Pluristem Therapeutics Inc.

Pluristem Strengthens Its Position in Asia, Awarded Two New Patents in Hong Kong for Critical Limb Ischemia and Muscle Regeneration

HAIFA, Israel, Sept. 13, 2017 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (NASDAQ:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, announced today that the company...
September 11, 2017 08:16 ET | Source: Pluristem Therapeutics Inc.

Pluristem Reports Fourth Quarter and Fiscal 2017 Corporate and Financial Highlights

Company steps up its clinical platform with pipeline of three late-stage clinical indicationsAll late-stage programs are supported and funded by 3rd parties with over $19 million in non-dilutive...
September 11, 2017 06:05 ET | Source: Gilat Satellite Networks Ltd.

Globe Awards Gilat Five Year Multi-Million Dollar Contract for Managed Service Satellite Backhaul for Cellular Services

PETAH TIKVA, Israel, Sept. 11, 2017 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ:GILT) (TASE:GILT), a worldwide leader in satellite networking technology, solutions and services,...
September 07, 2017 07:00 ET | Source: Kamada Ltd.

Kamada to Present Corporate Overview at Two Investor Conferences in September

REHOVOT, Israel, Sept. 07, 2017 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announced today that Amir...
September 06, 2017 09:00 ET | Source: RADA Electronic Industries Ltd.

RADA Provides Update on Recent Capital Raising Activity

NETANYA, Israel, Sept. 06, 2017 (GLOBE NEWSWIRE) -- RADA Electronic Industries Ltd. (Nasdaq:RADA) announced that following recent capital raising activity with institutional investors, the...
September 06, 2017 08:45 ET | Source: My Size, Inc.

My Size Introduces SizeIT, a Smart Measuring Tape SDK

AIRPORT CITY, Israel, Sept. 06, 2017 (GLOBE NEWSWIRE) -- My Size, Inc. (the “Company” or “My Size”) (NASDAQ:MYSZ) (TASE:MYSZ), developer of proprietary, smartphone measurement applications, expanded...